21 May 2013
Keywords: cypros, ceresine, shows, promise, stroke, pharmaceutical, reported
Article | 23 February 1999
Cypros Pharmaceutical has reported promising data from a Phase II trialof its pipeline product Ceresine (CPC-211) in patients with ischemic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 July 1999
© 2013 thepharmaletter.com